Archive for September, 2010

Advice for dealing with school bullies

Ann MacDonald

Contributor, Harvard Health

Although adults sometimes dismiss it as a childhood rite of passage, bullying in school is now recognized as a form of aggression that may have long-lasting psychological ramifications — for both victims and perpetrators. Most research on bullying has been done in Australia and Europe, where rates of frequent bullying range from 2% of youths […]

Prostate cancer vaccine approved by the FDA

Sipuleucel-T (Provenge), a “vaccine” that uses a patients immune system to fight advanced stage disease, was approved by the FDA in April 2010. The vaccine does not prevent cancer; rather, it helps men with advanced stage, hormone-resistant disease live longer.

Rethinking when to biopsy

A prostate cancer diagnosis may send a man to the operating room or drive him to get radiation therapy—even when the cancer is unlikely to spread or cause harm. That’s causing some to wonder when a biopsy should really be done.

Statins, aspirin may hide prostate cancer

Research suggests that these drugs could potentially mask changes in a man’s PSA and interfere with the detection of prostate cancer.

Degarelix approved for advanced prostate cancer

This injectable form of hormone therapy received FDA approval in December 2008.

HIFU controls recurrent cancer in short run

Researchers find that high-intensity focused ultrasound (HIFU) may be effective in treating localized recurrent prostate cancer while also minimizing the chances of side effects.

Hormone therapy doesn’t seem to raise risk of cardiac death

Prostate cancer drug treatments that block the activity of hormones have been associated with a higher risk of heart attack and heart disease. But a 2009 study suggests that these drugs may not cause cardiovascular problems after all.

Statins show no effect on PSA levels

Ever since the FDA approved the first cholesterol-lowering statin in 1987, use of the drugs has steadily increased, with an estimated 13 million Americans taking them to ward off heart and vascular disease. Recently, statins have gained additional attention, thanks to studies showing the drugs might have anticancer properties. But researchers have inconsistent answers to […]